CBIA
Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Santa Monica, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2023 Q2 | -0.00 | $0 | -$157,022 |
| 2023 Q1 | -0.01 | $0 | -$1,040 |
| 2022 Q4 | -0.00 | $0 | -$1,040 |
| 2022 Q3 | -0.00 | $0 | -$80 |
| 2022 Q2 | -0.00 | $0 | -$3,192 |
| 2022 Q1 | -0.00 | $0 | $678 |
| 2021 Q4 | -0.00 | $0 | $678 |
| 2021 Q3 | -0.00 | $0 | -$1,755 |